Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements
Background:
That thrombocytopenia results in increased mortality or
transfusion requirements has not been confirmed by previous studies. We
performed a case-control study in which 36 patients who developed severe
thrombocytopenia of less than 50×109 platelets/l were carefully
matched for the severity of underlying disease and other important
variables.
Results:
Seventeen (47%) thrombocytopenic patients died, versus 10 (28%)
matched control patients who were not thrombocytopenic.Nine pairs had a
discordant outcome, and in eight of these pairs the thrombocytopenic patient
died (exact binomial probability 0.037). The estimated attributable mortality
was 19.5% (95% confidence interval 3.2⌓35.8), and the estimated odds ratio was
2.7 (95% confidence interval 1.02⌓7.10). Thrombocytopenic patients had
comparable values for severity of illness scores between day of admission and
day of thrombocytopenia, in contrast with control patients who had a
statistically significant decrease in severity of illness scores during the
same period. Thirty (83%) of the thrombocytopenic patients required transfusion
of blood products, versus 21 (58%) control patients (paired χ2
test 4.92, P < 0.04). The estimated attributable transfusion
requirement was 25% (95% confidence interval 5.4⌓44.6), and the estimated odds
ratio was 1.52 (95 confidence interval 1.05⌓2.20).
Conclusion:
The present study suggests that thrombocytopenia of less than
50 × 109 platelets/l may be a marker for more severe illness and
increased risk of death, rather than causative, because a true causal
relationship is not established. Thrombocytopenia also leads to an excess of
blood product consumption.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@nih.gov"
}
|
| description | Background: That thrombocytopenia results in increased mortality or transfusion requirements has not been confirmed by previous studies. We performed a case-control study in which 36 patients who developed severe thrombocytopenia of less than 50×109 platelets/l were carefully matched for the severity of underlying disease and other important variables. Results: Seventeen (47%) thrombocytopenic patients died, versus 10 (28%) matched control patients who were not thrombocytopenic.Nine pairs had a discordant outcome, and in eight of these pairs the thrombocytopenic patient died (exact binomial probability 0.037). The estimated attributable mortality was 19.5% (95% confidence interval 3.2⌓35.8), and the estimated odds ratio was 2.7 (95% confidence interval 1.02⌓7.10). Thrombocytopenic patients had comparable values for severity of illness scores between day of admission and day of thrombocytopenia, in contrast with control patients who had a statistically significant decrease in severity of illness scores during the same period. Thirty (83%) of the thrombocytopenic patients required transfusion of blood products, versus 21 (58%) control patients (paired χ2 test 4.92, P < 0.04). The estimated attributable transfusion requirement was 25% (95% confidence interval 5.4⌓44.6), and the estimated odds ratio was 1.52 (95 confidence interval 1.05⌓2.20). Conclusion: The present study suggests that thrombocytopenia of less than 50 × 109 platelets/l may be a marker for more severe illness and increased risk of death, rather than causative, because a true causal relationship is not established. Thrombocytopenia also leads to an excess of blood product consumption. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Government Data Source",
"mediaType": "text/html",
"description": "Visit the original government dataset for complete information, documentation, and data access.",
"downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29031/"
}
]
|
| identifier | https://healthdata.gov/api/views/jk28-pd3f |
| issued | 2025-07-13 |
| keyword |
[
"case-control-study",
"nih",
"surgical-icu",
"thrombocytopenia-mortality",
"transfusion-requirements"
]
|
| landingPage | https://healthdata.gov/d/jk28-pd3f |
| modified | 2025-09-06 |
| programCode |
[
"009:034"
]
|
| publisher |
{
"name": "National Institutes of Health",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements |